Abstract
Introduction

18
Genetic and phenotypic variations among humans have been shaped by many factors, including migration 19 histories, geodemographic events, and environmental background [1] [2] [3] [4] [5] . As a result, the underlying genetic 20 architecture of a given complex trait -defined here in terms of 'polygenicity' (the number of variants with 21 nonzero effects) [6] [7] [8] [9] [10] and the coupling of causal effect sizes with minor allele frequency (MAF) 11, 12 , linkage 22 disequilibrium (LD) [13] [14] [15] , and other genomic features 16 -varies among ancestral populations. While the vast 23 majority of genome-wide association studies (GWAS) to date have been performed in individuals of 24
European descent [17] [18] [19] [20] , growing numbers of studies performed in individuals of non-European ancestry [21] [22] [23] [24] [25] [26] [27] 25 have created opportunities for well-powered transethnic genetic studies 21, 22, 24, 26, [28] [29] [30] [31] [32] [33] .
26
Risk regions identified through GWAS tend to replicate across populations 17, 21, 22, [33] [34] [35] , indicating 27 that complex traits have shared genetic components among populations. Indeed, for certain post-GWAS 28 analyses such as disease mapping 23, 31, 36 and statistical fine-mapping 28, [37] [38] [39] [40] , under the assumption that two 29 populations share one or more causal variants, population-specific LD patterns can be leveraged to improve 30 performance over approaches that model a single population. On the other hand, several studies have shown 31 that heterogeneity in genetic architectures limits transferability of polygenic risk scores (PRS) across 32 populations 5, [41] [42] [43] [44] [45] [46] [47] [48] ; critically, if applied in a clinical setting, existing PRS may exacerbate health disparities 33 among ethnic groups 49 . The population-specificity of existing PRS as well as estimates of transethnic 34 genetic correlations less than one reported in the literature 30, [50] [51] [52] [53] indicate that (1) LD tagging and allele 35 frequencies of shared causal variants vary across populations, (2) that a sizeable number of causal variants 36 are population-specific, and/or (3) that causal effect sizes vary across populations due to, for example, 37 different gene-environment interactions. For example, due to population-specific LD, a single genetic 38 variant that is significantly associated with a trait in two populations may actually be tagging distinct 39 population-specific causal variants ( Figure 1 ). Conversely, two distinct associations in two populations may 40 be driven by the same underlying causal variants (i.e. colocalization). Thus, identifying shared and 41 population-specific components of genetic architecture could help improve transethnic analyses (e.g., 42
transferability of PRS across populations 19, 41, 42, 45, 46 ) and uncover novel disease etiologies. 43
In this work, we introduce PESCA (Population-spEcific/Shared Causal vAriants), an approach that 44 requires only GWAS summary association statistics and ancestry-matched estimates of LD to infer genome-45 wide proportions of population-specific and shared causal variants for a single trait in two populations. 46
These estimates are then used as priors in an empirical Bayes framework to localize and test for enrichment 47 of population-specific/shared causal variants in regions of interest. In this context, a "causal variant" is a 48 variant measured in the given GWAS that either has a nonzero effect on the trait (e.g., a nonsynonymous 49 variant that alters protein folding) or tags a nonzero effect at an unmeasured variant through LD. It is 50 therefore important to note that the set of "causal variants" that PESCA aims to identify is defined with 51 respect to the set of variants included in the GWAS and can contain variants with indirect nonzero effects 52 that are statistical rather than biological in nature (this is analogous to the definition of SNP-heritability, 53
which is also a function of a specific set of SNPs 11, [54] [55] [56] ). Through extensive simulations, we show that our 54 method yields approximately unbiased estimates of the proportions of population-specific/shared causal 55 variants if in-sample LD is used and slightly upward-biased estimates if LD is estimated from an external 56 reference panel. We then show that using these estimates as priors to perform fine-mapping (Methods) 57 produces well-calibrated per-SNP posterior probabilities and enrichment test statistics. We note that the 58 definition of enrichment used here is related to, but conceptually distinct from, definitions of SNP-59 heritability enrichment 13, 16 . Under our framework, an enrichment of causal SNPs greater than 1 indicates 60 that, compared to the genome-wide background, there are more causal SNPs in that region than expected 57, 58 61 (Methods). In contrast, an enrichment of SNP-heritability greater than 1 indicates that the average per-SNP 62 effect size in the region is larger than the genome-wide average per-SNP effect size. 63
We apply our approach to publicly available GWAS summary statistics for 9 complex traits and 64 diseases in individuals of East Asian (EAS) and European (EUR) ancestry (average NEAS = 94,621, NEUR = 65 103,507) (Table 1) , restricting to common SNPs (MAF > 5%) and using 1000 Genomes 59 to estimate 66 ancestry-matched LD. On average across the 9 traits, we estimate that approximately 80% (S.D. 15%) of 67 common SNPs that are causal in EAS and 84% (S.D. 8%) of those in EUR are shared by the other population. 68
Consistent with previous studies based on SNP-heritability 55, 60 , we find that high-posterior SNPs are 69 distributed uniformly across the genome. We observe that population-specific GWAS risk regions have, on 70 average across the 9 traits, a 2.8x enrichment of shared high-posterior SNPs relative to the genome-wide 71 background, suggesting that many EAS-specific and EUR-specific GWAS risk regions harbor shared causal 72
SNPs that are undetected in the other population due to differences in LD, allele frequencies, and/or GWAS 73 sample size. The effects of SNPs with posterior probability > 0.8 of being causal (for any causal 74 configuration) are highly correlated between EAS and EUR, concordant with replication slopes between 75 EAS and EUR marginal effects close to 1 that have been reported for several complex diseases 33 and with 76 strong transethnic genetic correlations previously reported for the same traits analyzed in this work (average 77 ! " # = 0.79 ± 0.07 s.e.m. across the 9 traits) 51 . Finally, we show that regions flanking genes that are 78 specifically expressed in trait-relevant tissues 61 harbor a disproportionate number of shared high-posterior 79
SNPs -many of the same tissue-specific gene sets are also enriched with SNP-heritability, implying that 80 SNP-heritability enrichments are driven by many low-effect SNPs rather than a small number of high-effect 81 SNPs. Our results suggest that common causal SNPs have similar etiological roles in EAS and EUR and 82 that transferability of PRS and other GWAS findings across populations can be improved by explicitly 83 correcting for population-specific LD and allele frequencies. 84
85
Material and Methods
86
Distribution of GWAS summary statistics in two populations
87
For a given complex trait, we model the causal statuses of SNP * in two populations as a binary vector of 88 size two, + , = -,. -,/ , where each bit, -,. ∈ {0,1} and -,/ ∈ {0,1}, represents the causal status of SNP * in 89 populations 1 and 2, respectively. + , = 00 indicates that SNP * is not causal in either population; + , = 01 90 and + , = 10 indicate that SNP * is causal only in the first and second population, respectively; and + , = 91 11 indicates that SNP * is causal in both populations. We assume + , follows a multivariate Bernoulli (MVB) 92 distribution 62, 63 93 + , ~ MVB(; << , ; <. , ; .< , ; .. ) 94 in order to facilitate optimization and interpretation (Supplemental Note). Assuming the causal status vector 95 of a SNP is independent from those of other SNPs (+ , ⊥ + ? for * ≠ A), the joint probability of the causal 96 statuses of B SNPs is PrE+ . , ⋯ , + G H = ∏ Pr(+ , ) G ,J.
.
97
Given two genome-wide association studies with sample sizes K . and K / for the first and second where g = (; << , ; <. , ; .< , ; .. ) is the vector of parameters of the MVB distribution. In practice, we partition 110 the genome into approximately independent regions 64 and model the distribution of Z-scores at all regions 111 as the product of the distribution of Z-scores in each region (Supplemental Note). 112
114
Estimating genome-wide proportions of population-specific/shared causal SNPs
115
We use Expectation-Maximization (EM) coupled with Markov Chain Monte Carlo (MCMC) to maximize 116 the likelihood function in Equation (1) over the MVB parameters g . We initialize g to g = 117 (0, −3.9, −3.9, 3.9) which corresponds to 2% of SNPs being causal in population 1, 2% being causal in 118 population 2, and 2% being shared causals. In the expectation step, we approximate the surrogate function 119 rEg|g (s) H using an efficient Gibbs sampler; in the maximization step, we maximize rEg|g (s) H using 120 analytical formulae (Supplemental Note). From the estimated g, denoted g * , we recover the proportions of 121 population-specific and shared causal SNPs. For computational efficiency, we apply the EM algorithm to 122 each chromosome in parallel and aggregate the chromosomal estimates to obtain estimates of the genome-123
wide proportions of population-specific/shared causal SNPs (Supplemental Note). 124
125
Evaluating per-SNP posterior probabilities of being causal in a single or both populations 126 We estimate the posterior probability of each SNP to be causal in a single population (population-specific) 127 or both populations (shared), using the estimated genome-wide proportions of population-specific and 128 shared causal variants (obtained from g * ) as prior probabilities in an empirical Bayes framework. 
. Since SNPs in a region are highly correlated, 140 invalidating the use of jackknife to estimate standard errors, we refrain from reporting standard errors of 141 the posterior expected regional numbers of population-specific/shared causal SNPs. 
Enrichment of population-specific/shared causal SNPs in functional annotations
158
We define the enrichment of population-specific/shared causal SNPs in a functional annotation as the ratio 159 between the posterior and prior expected numbers of population-specific/shared causal SNPs. Specifically, 160
we estimate the enrichment of population-specific/shared causal SNPs in a functional annotation k relative 161 to the genome-wide background as 162
where ä ∈ {01, 10, 11}, x ],ä is the number of population-specific (ä = 01 or ä = 10) or shared (ä = 11) 164 , approximately follow a t-distribution with degrees of freedom equal to the number of blocks minus 170 one 65 . Since we are interested in identifying categories of SNPs that harbor more population-specific/shared 171 causal SNPs than expected (i.e. enrichment > 1), we report P-values from a one-tailed t-test where the null 172
We note that our definition of enrichment of causal SNPs is related to, but conceptually different 174 from, enrichment of SNP-heritability 13, 16, 66 . A positive enrichment of causal SNPs in a functional category 175
indicates that, compared to the genome-wide background, there are more causal SNPs in that category than 176 expected; a positive enrichment of SNP-heritability in a category indicates that the average per-SNP effect 177 size in the category is larger than the genome-wide average per-SNP effect size. Given genotypes at M SNPs for n1 and n2 individuals in populations 1 and 2, respectively, we 187 assume the standard linear models ó ò = ô ò ö ò + õ ò (population 1) and ó ú = ô ú ö ú + õ ò (population 2). Table 1 ). The European-205 ancestry BMI GWAS is doubly corrected for genomic inflation factor 72 , which induces downward-bias in 206 the estimated SNP-heritability; we correct this bias by re-inflating the Z-scores for this GWAS by a factor 207 of 1.24. For all traits, we restrict to SNPs with MAF > 5% in both populations to reduce noise in the LD 208 matrices estimated from 1000 Genomes 73 . We use PLINK 71 We observe a slight decrease in accuracy as the effective sample size, the product of SNP-229 heritability and sample size (T × ℎ # / ), decreases ( Figures S1-S5 ). This is expected as the likelihood of the 230 GWAS summary statistics is a function of T × ℎ # / (Methods) -as the expected per-SNP variance at causal 231 SNPs (T × ℎ # / divided by the number of causal SNPs) decreases, GWAS summary statistics provide less 232 information on the causal status of each SNP. Since it is often the case that the sample size of one GWAS 233 is larger than that of the other, we perform simulations in which SNP-heritability is fixed to 0.05 in both 234 populations, the EAS sample size is fixed to T ÉÑÖ = 10 ™ , and the EUR sample size is varied such that the 235 effective sample size of the EUR GWAS is 1-5x larger than that of the EAS GWAS. We find that the 236 genome-wide estimators are relatively robust with in-sample LD; with external estimates of LD, when 237 effective sample size differs by a factor of 2 or more, the estimator for the number of EUR-specific causal 238
SNPs becomes less biased while the EAS-specific and shared causal estimators become increasingly 239 inflated ( Figure S6 ). In addition, while it seems likely that the effect sizes of shared causal SNPs would be 240 positively correlated across populations, the PESCA model assumes zero cross-population correlation in 241 order to facilitate inference (Methods). We therefore perform simulations under an alternative model in 242 which EAS and EUR effect sizes at shared causal SNPs are positively correlated and find that our estimates 243 of the genome-wide numbers of shared and population-specific causal SNPs become increasingly inflated 244 and deflated, respectively, as the correlation increases from 0 to 1 ( Figure S7 (Figures S8-S9 ). As expected, as the simulated 251 proportion of shared causal SNPs increases, the average correlation between the posterior probabilities and 252 true causal status vectors increases for the shared causal configuration and decreases for the population-253 specific causal configurations ( Figures S8-S9 ). Since we did not have access to individual-level genotypes 254
sampled from an ancestral group with shorter LD blocks (e.g., African-ancestry individuals), we use the 255 EAS and EUR LD scores of each SNP as proxies for the strength of LD in the region housing the SNP to 256 investigate the impact of population-specific LD patterns on the per-SNP posterior probabilities. Among 257 the true causal SNPs (shared or population-specific), the posterior probabilities are relatively invariant to 258 the magnitude of the EAS and EUR LD scores ( Figure S10 ). In other words, under the PESCA framework, 259 power to detect a given true causal SNP does not depend on its LD score in either population. Restricting 260 to a set of "high-posterior SNPs" (defined here as SNPs with posterior probability greater than some 261 threshold ´), we investigate whether PESCA systematically misclassifies SNPs based on the magnitude of 262 their LD scores. Again, we observe that the average EAS and EUR LD scores do not vary significantly 263 between the true and false positive classifications (Table S1 ). We then assessed whether our proposed 264 statistics for testing for enrichment of population-specific/shared causal SNPs in functional annotations 265 (Methods) are well-calibrated under the null hypothesis of no enrichment. Overall, when both population-266 specific and shared causal SNPs are drawn at random, the enrichment test statistics are conservative at 267 different levels of polygenicity and GWAS power (T × ℎ # / ), irrespective of whether in-sample LD or 268 external reference LD is used (Figures S11-S16) . 269
Finally, we evaluated the computational efficiency of each stage of inference. In the first stage of 270 inference -estimating genome-wide proportions of population-specific/shared causal SNPs -the 271 maximization step of the EM algorithm uses Gibbs sampling to efficiently sample from the posterior of the 272 causal status vectors (Supplemental Note). We set both the number of burn-in iterations and the number of 273 samples to 5,000 for the MCMC within the maximization step and found that the overall EM typically 274 converged within 200 iterations (Figures S17-S19 ). Run-time per EM-iteration increases with the number 275 of causal SNPs ( Figure S20) ; for example, in simulations with a total of 8,589 SNPs, when the maximum 276 number of EM iterations was set to 200, PESCA took an average of 90 minutes to obtain estimates in 277 simulations with 20 randomly selected causal variants and 360 minutes in simulations with 100 randomly 278 selected causal SNPs. This is expected because the likelihood function being maximized is proportional to 279 the Bayes factor of only the causal SNPs (Supplemental Note). In the second stage of inference -evaluating 280 posterior probabilities for each SNP -we set both the number of burn-in iterations and the number of 281 samples to 5,000 for the MCMC and, to ensure stable estimates of the posterior probability, we report the 282 average posterior probability from 20 iterations of the Gibbs sampling procedure (Supplemental Note). The 283 average run-time was 5 minutes in simulations with 20 causal variants and 28 minutes in simulations with 284 100 causal variants ( Figure S20 ). We note that both stages of inference can be parallelized to decrease run 285
time. 286 287
Expected genome-wide proportions of shared causal SNPs for 9 complex traits 288 We obtained publicly available GWAS summary statistics for 9 (non-independent) complex traits and 289 diseases in individuals of EAS and EUR ancestry (average NEAS = 94,621, NEUR = 103,507) ( Table 1) and 290 applied PESCA to estimate the genome-wide proportions of population-specific/shared common causal 291
SNPs (Methods). To ensure convergence, we applied 750 EM iterations for each trait (Figures S21-S23). 292
Across the 9 traits, the estimated proportions of common causal SNPs in each population (the sum of the 293 numbers of population-specific and shared causal SNPs) are consistent with previously reported estimates 294 of polygenicity in single populations 7, 8, 55, 75, 76 . For example, we estimate that approximately 10% of common 295
SNPs have nonzero effects on BMI in both EAS and EUR and that 2-3% have nonzero effects on the lipids 296 traits ( Table 1) . The low estimates for major depressive disorder and rheumatoid arthritis may be explained 297 in part by their small GWAS sample sizes. While there is heterogeneity in the estimated proportions of 298 shared causal SNPs across the 9 traits, we find that most common causal SNPs are shared between the 299 populations, consistent with findings from previous studies 33 . For example, for BMI, we estimate that 300 approximately 96% of common causal SNPs in each population are also causal in the other; for total 301 cholesterol (TC), we estimate that 73% of common causal SNPs in EAS and 77% of those in EUR are 302 shared by both populations (Table 1) . probabilities by chromosome, we find that the posterior expected numbers of EAS-specific, EUR-specific, 312 and shared causal SNPs per chromosome are highly correlated with chromosome length (Figures S32-S34) , 313 recapitulating previous findings based on regional SNP-heritability 55, 60 . 314
315
Distributions of high-posterior SNPs across GWAS risk regions 316
We aggregate per-SNP posterior probabilities within GWAS risk regions that are EAS-specific, EUR-317 specific, or shared by both populations and find that most GWAS risk regions harbor two or more shared 318 high-posterior SNPs (Figure 4, Figures S35-S39) , concordant with previous findings on allelic 319 heterogeneity of complex traits 55, 77, 78 . On average across the 9 traits, we observe a 2.8x enrichment of shared 320 high-posterior SNPs in population-specific GWAS risk regions relative to the genome-wide background. 321 (Figure 4, Figures S35-S39) . 328
For each causal configuration (EAS-specific, EUR-specific, or shared), we examine the effect sizes 329 of high-posterior SNPs (posterior probability > 0.8) in EAS and EUR ( Figure 5 ). Across the 9 traits, the 330 majority of EAS-specific high-posterior SNPs are nominally significant (B¨≠ ÑÖ < 5 × 10 íAE ) either in the 331 EAS GWAS only or in both GWASs. While five EUR-specific high-posterior SNPs are nominally 332 significant in only the EAS GWAS, the majority are nominally significant either in the EUR GWAS only 333 or in both GWASs. We observe strong correlations between the effect sizes in EAS and EUR for all three 334 that are driven by SNPs that are nominally significant in both GWASs ( Figure 5 ). Taken together, these 336 results suggest that most population-specific GWAS risk regions harbor shared causal variants that are 337 undetected in the other population due to heterogeneity in LD structures, allele frequencies, and/or GWAS 338 sample sizes 33 . 339
340
Enrichment of high-posterior SNPs near genes expressed in trait-relevant tissues 341
Motivated by recent work that found enrichment of SNP-heritability in regions near genes that are 342 "specifically expressed" in trait-relevant tissues and cell types (referred to as "SEG annotations"), we tested 343 for enrichments of population-specific and shared causal SNPs in the same 53 tissue-specific SEG 344 annotations 61 . For a given causal configuration, the enrichment of causal SNPs in an annotation is defined 345 as the ratio between the posterior and prior expected numbers of causal SNPs in the annotation (Methods). 346
For 8 of the 9 traits, we find significant enrichment of shared high-posterior SNPs in at least one SEG 347 annotation (P-value < 0.05/53 to correct for 53 tests per trait) (Figures S40-S44 ). All SEG annotations with 348 significant enrichments of population-specific high-posterior SNPs are also enriched with shared high-349 posterior SNPs for the same trait, providing additional evidence that many signatures of population-specific 350 genetic architecture are induced by population-specific LD and allele frequencies rather than distinct 351 genetic etiologies. We do not find enrichment of any high-posterior SNPs in any SEG annotation for major 352 depressive disorder (MDD) (Figure S44 ), which could be due to low GWAS sample sizes (Table 1) . Finally, 353
for each SEG annotation, we obtain a meta-analyzed transethnic SNP-heritability enrichment by computing 354 the inverse-variance weighted average of the EAS and EUR SNP-heritability enrichments (which are 355 obtained separately using stratified LD score regression 13, 16 ). We observe a strong correlation between the 356 meta-analyzed SNP-heritability enrichments and the enrichments of shared high-posterior SNPs (Figure 6) , 357
suggesting that SNP-heritability enrichments are largely driven by many low-effect SNPs rather than a 358 small number of high-effect SNPs. 359
360
Discussion
361
We have presented PESCA, a method for estimating the genome-wide proportions of SNPs with nonzero 362 effects in a single population (population-specific) or in two populations (shared) from GWAS summary 363 statistics and estimates of LD. We applied PESCA to EAS and EUR GWAS summary statistics for 9 364 complex traits and find that, while the lipids traits have significantly more EAS-specific common causal 365 SNPs compared to the remaining traits, the majority of common causal SNPs are shared by both populations. 366
Regions that harbor statistically significant GWAS associations for one population are enriched with SNPs 367 with high-posterior probability of being causal in both populations; moreover, high-posterior SNPs 368 (posterior probability > 0.8 for any causal configuration) have highly correlated effect sizes in EAS and 369 EUR, recapitulating results of previous studies 33 . For all traits except MDD, we identify tissue-specific SEG 370 annotations 66 enriched with shared high-posterior SNPs and observe that all SEG annotations enriched with 371 population-specific high-posterior SNPs are a subset of those enriched with shared high-posterior SNPs. 372
Taken together, our results indicate that most population-specific GWAS risk regions contain shared 373 common causal SNPs that are undetected in the second population due to differences in LD or allele 374
frequencies. This suggests that localizing shared components of genetic architecture and explicitly 375 correcting for population-specific LD and allele frequencies may help improve transferability of results 376 from well-powered European-ancestry studies to other understudied populations. Based on the simulation 377 results in Figure S1 (in which 100% of causal SNPs are shared) and our estimates of SNP-heritability for 378 the traits in Table 1 , we recommend applying PESCA to summary statistics for which the effective per-SNP 379 sample size, T × ℎ # / divided by the number of causal SNPs, is at least 3 for both GWASs. For a typical 380 quantitative trait (e.g., Table 1 ), this corresponds to a total effective sample size of approximately T × ℎ # / > 381 10,000. 382
We conclude by discussing the caveats and limitations of our analyses. First, the estimated 383
proportions of causal SNPs must be interpreted with caution as they can be influenced by gene-environment 384
interactions. For example, if a SNP has a nonzero effect on a trait only in the presence of environmental 385 factors that are specific to EAS-ancestry individuals, PESCA will interpret that SNP as an EAS-specific 386 causal SNP even though it would have a nonzero effect in Europeans in the presence of the same 387 environmental factors. 388
Second, we chose to analyze a set of traits that were present in both the UK Biobank and Biobank 389
Japan and for which GWAS summary statistics were publicly available. Since most publicly available 390 summary statistics of large-scale GWAS are meta-analyses of smaller studies, in-sample LD is often 391 unavailable. While PESCA with in-sample LD is relatively robust to differential GWAS power, with 392 external LD, performance decreases when the GWAS effective sample sizes differ by more than a factor of 393 2x. We note, however, that for the real traits analyzed in this work, effective sample size differs by a 394 maximum factor of 2x (mean corpuscular hemoglobin; Table 1 ). Additionally, PESCA currently cannot be 395 applied to admixed populations if in-sample LD is unavailable. An extension of PESCA to properly account 396 for external/noisy estimates of LD would thus increase its utility; we defer a thorough investigation of this 397 to future work. In parallel, in light of ongoing efforts at several institutions to establish biobanks 69, 70, [79] [80] [81] , 398
we believe that well-powered GWASs (with in-sample LD) will become increasingly available for diverse 399 and admixed populations. Another challenge is that many publicly available summary statistics were 400 computed from fixed-effect meta-analyses or linear mixed models. Since the PESCA model is defined with 401 respect to GWAS marginal effects estimated by ordinary least squares (OLS) regression, it is unclear 402 whether PESCA is sensitive to non-OLS association statistics, which have different statistical properties; 403 we defer a thorough investigation of this to future work. 404
Third, we restricted our analyses to SNPs with MAF > 5% in both populations to reduce noise in 405 the LD matrices estimated from external reference panels. Consequently, the estimates we report in this 406 work do not capture effects of low frequency or rare variants that are not well-tagged by common SNPs. 407
Furthermore, since most common variants are shared across continental populations and rarer variants tend 408 to localize among closely related populations 73 , our study design undersamples population-specific causal 409 variants. We note, however, that lower MAF thresholds can be used if in-sample LD is available. We also 410 note that for the purpose of improving transferability of polygenic risk scores (PRS) across populations, 411 prediction accuracy depends largely on the accuracy of the PRS weights at common SNPs (the average per-412 SNP contribution to total SNP-heritability is larger for common SNPs than for low frequency or rare 413 variants 11 Table 1 : Estimated numbers and percentages of population-specific/shared common causal SNPs for 9 complex traits. We estimated genome-wide SNP-heritability using LD score regression 54 with the intercept constrained to 1 (i.e. assuming no population stratification). Transethnic genetic correlation estimates (! " # ) computed from a similar set of summary statistics were obtained from a previous study 51 . Standard errors of the estimated numbers of population-specific/shared causal SNPs were computed using the last 50 iterations of the EM-MCMC algorithm. . However, due to population-specific LD, SNP 3 is observed to be GWAS-significant in both populations. The stars in the rightmost plots represent the SNPs with true nonzero effects; the GWAS-significant SNP is highlighted in a darker color. EAS-specific EUR-specific shared having significant associat ions in Figure 5 : Marginal regression coefficients of high-posterior SNPs for 9 complex traits. Each plot corresponds to one of the three causal configurations of interest: EAS-specific (A), EUR-specific (B), and shared (C). Each point represents a SNP with posterior probability > 0.8 for a single trait. The x-axis and yaxis mark the marginal regression coefficients in the EAS-ancestry GWAS and EUR-ancestry GWAS, respectively. The colors indicate whether the SNP is nominally significant (! "#$% < 5 × 10 +-) in both GWASs (purple), the EAS GWAS only (orange), the EUR GWAS only (green), or in neither GWAS (gray). The gray band marks the 95% confidence interval of the regression line.
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